Clinical Trial Update: IVIG (Gamunex-C) Treatment Study for POTS Subjects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/Phase 2 study evaluating intravenous immunoglobulins (Gamunex-C) for Postural Tachycardia Syndrome, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Tachycardia Syndrome

Drugs mentioned

• Gamunex-C (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Postural Tachycardia Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-09-19